Yu and collaborators showed that increasing the FasL expression by knocking down microRNA Let-7a in bone marrow-derived MSC could induce CD3 T-cell apoptosis, both in vitro and in vivo, these cells proving more potent in the treatment of graft versus host disease and experimental colitis in murine models [32]. This evidence concerns the gene FASLG and colitis.